RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
@drharshvardhan @CovidIndiaSeva @PMOIndia @PrakashJavdekar
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
@sahara_samay @PMOIndia
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
Hopefully this is a good news !!! 👇👇👇 Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial - The Lancet https://t.co/0NTsQxzcR
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
@abledoc @TFORDCOVID19 @ICMRDELHI @ProfBhargava @MoHFW_INDIA
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
🧐カレトラだけじゃなく他の薬も併用した方が効いた(香港) ✅COVID19患者127名を コンビ群(ロピナビル/リトナビル、リバビリン、IFNβ-1b)と対照群(ロピナビル/リトナビル)で比較 😊PCR陰性になるまでの期間が短縮(7vs12日) 😊副作用に有意差なし https://t.co/G4mozOYusK
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
#Pakistan @SaeedGhani1 @SindhCMHouse @murtazawahab1 @SHABAZGIL @Dr_YasminRashid
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial - The Lancet https://t.co/U12yy9Galb
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…